Synopsis
The ISMRM
has launched the “MR Value Initiative”, to encourage innovative optimization the
value of MR-based diagnostic technologies.
Both the numerator (clinical benefit) and the denominator (cost) of the
value ratio can be targeted by scientific and technical innovation. Studies have shown that investigators in
medical imaging generate innovations at a high rate, and that these inventions can
often be readily translated, with extraordinary impact on patient care. This presentation focuses on identifying
time-tested strategies that aspiring innovators can use to improve the chances
that their work will have an impact and perhaps make the world a better place. The Oxford
dictionary defines value as “the
worth of something compared to the price paid or asked for it”. The ISMRM has launched the “MR Value
Initiative”, to encourage development of innovative ways to optimize the value
of magnetic resonance-based diagnostic technologies. “Value” can be considered to be a ratio
between clinical benefit and cost.
Increasing the value of MRI-based technologies could allow these
amazingly powerful diagnostic tools to be used more widely and proactively for
the benefit of patients.
Efforts to
maximize the ratio of clinical benefit
to cost will inevitably involve the
domains of medical evidence, medical governance, and medical economics. However, the exciting proposition for members
of the ISMRM is that both the numerator (clinical benefit) and the denominator (cost)
of the value ratio can be targeted by scientific and technical innovation.
The main
premise underlying this presentation is that, compared to research in other
areas of medicine, investigators in medical imaging generate innovations at a
high rate, that these inventions are often notable for the fact that they can
be readily translated from the laboratory to clinical practice, and that these
innovations often have extraordinary impact on patient care.
A study
published in Health Affairs more than a decade ago surveyed physicians about 30
major medical innovations of the twentieth century, asking which would be
missed most in the care of their patients if they did not exist. The list of innovations included drugs such
as statins and third generation antibiotics, interventions such as vascular
stenting and hip joint replacement, and various diagnostic testing
modalities. The innovations that topped
the list for impact were MRI and CT.
The Academy
of Radiology Research is an organization supported by the ISMRM which is
dedicated to advocacy for increased federal support for imaging research in the
US. The Academy has argued that the
funding invested in imaging research at the NIH and other federal agencies is actually
disproportionally low compared with other areas of medical research when
considering impact and return on
investment,. In order to substantiate
this notion, the academy conducted a study that assessed rate at which NIH-funded
research produces patented inventions. It
is known that, in addition to their intrinsic value as solutions to problems,
patented inventions are a major driver of long term regional economic
performance in the US. The study showed
that between 2003 and 2012, research funded by the National Institute for
Biomedical Imaging and Bioengineering (NIBIB) yielded patented inventions at a
rate more than four times higher than the average for all NIH
institutes.
What about
the impact of these inventions? A
standard approach for assessing the quality of patents, used in industry is to
assess the number of forward citations. This is the number of times that later
patents reference an earlier patent. A
highly-cited patent is more likely to have contributed new knowledge and
created new fields of opportunity than a patent that is rarely cited. The study by the Academy of Radiology
Research found that the average number of citations for inventions created as a
result of funding by the NIBIB was approximately twice that of the
overall NIH average [1]. These basic
conclusions of the Academy study were subsequently confirmed by an independent
study published by the Battelle institute in 2015 [2].
These
findings lend strong support to the notion that technology-focused research in
imaging science is highly productive of in terms of practical innovations and
impact. Why is this the case? One explanation might be that scientists in
our field often focus their work in what has been called “Pasteur’s Quadrant”
[3]. This approach focuses multidisciplinary
expertise on “use-inspired” research.
The work seeks to advance knowledge, while benefiting society [4].
The
remainder of this presentation focuses on identifying time-tested “Pasteur’s
Quadrant” strategies that aspiring innovators can use to improve the chances
that their work will have an impact and perhaps make the world a better place.
Acknowledgements
No acknowledgement found.References
1.
Kalutkiewicz
MJ, Ehman RL. Patents as proxies: NIH
hubs of innovation. Nat Biotechnol 2014;32:536–537.
2.
Patents as Proxies Revisited: NIH
Innovation 2000 to 2013. http://www.battelle.org/docs/tpp/battelle_2015_patents_as_proxies.pdf.
3.
Kalutkiewicz
MJ, Ehman RL, Bernstein MA. Patents and
Pasteur: why new metrics may point to imaging science as a model for
innovation. Magn Reson Med. 2014
Nov;72(5):1199-200.
4.
Stokes,
DE. Pasteur’s quadrant—basic science and
technological innovation. Washington, DC: Brookings Institution Press;
1997.